help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumantran, V. N.
Right arrow Articles by Feldman, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumantran, V. N.
Right arrow Articles by Feldman, E. L.

Endocrinology, Vol 132, 2017-2023, Copyright © 1993 by Endocrine Society


ARTICLES

Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells

VN Sumantran and EL Feldman
Department of Neurology, University of Michigan, Ann Arbor 48109.

In the human neuroblastoma cell line SH-SY5Y, insulin-like growth factors I (IGF-I) and II (IGF-II) are established mitogens, and IGF-I appears to promote SH-SY5Y neuronal differentiation. Studies show that c-myc gene product is a transcription factor associated with cell proliferation, and that c-myc messenger RNA levels decrease in differentiating SH-SY5Y neurons. Using Northern analysis we show that 24 h exposure of SH-SY5Y cells to IGF-I (3-10 nM) causes a 3- to 5-fold decrease in c-myc expression. The decrease in c-myc expression due to IGF-I is mediated via the type I IGF receptor and coincides with an IGF- I-mediated induction of the neuronal differentiation markers growth cone associated protein 43 and tissue type plasminogen activator. Under these conditions, IGF-I (10 nM) did not markedly affect the levels of Max messenger RNA expression. Thus, the differentiation promoting activity of IGF-I in SH-SY5Y cells in part due to IGF-I-dependent regulation of the expression of genes involved in neuronal differentiation.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. J. Jenkins and M. Besser
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2935 - 2941.
[Full Text] [PDF]


Home page
EndocrinologyHome page
H.-L. Cheng, M. Shy, and E. L. Feldman
Regulation of Insulin-Like Growth Factor-Binding Protein-5 Expression during Schwann Cell Differentiation
Endocrinology, October 1, 1999; 140(10): 4478 - 4485.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
D. Chambery, S. Mohseni-Zadeh, B. d. Galle, and S. Babajko
N-myc Regulation of Type I Insulin-like Growth Factor Receptor in a Human Neuroblastoma Cell Line
Cancer Res., June 1, 1999; 59(12): 2898 - 2902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Kim, P. S. Leventhal, A. R. Saltiel, and E. L. Feldman
Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation
J. Biol. Chem., August 22, 1997; 272(34): 21268 - 21273.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. S. Leventhal, E. A. Shelden, B. Kim, and E. L. Feldman
Tyrosine Phosphorylation of Paxillin and Focal Adhesion Kinase during Insulin-like Growth Factor-I-stimulated Lamellipodial Advance
J. Biol. Chem., February 21, 1997; 272(8): 5214 - 5218.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Menouny, M. Binoux, and S. Babajko
Role of Insulin-Like Growth Factor Binding Protein-2 and Its Limited Proteolysis in Neuroblastoma Cell Proliferation: Modulation by Transforming Growth Factor-{beta} and Retinoic Acid
Endocrinology, February 1, 1997; 138(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Singleton, V. M. Dixit, and E. L. Feldman
Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins
J. Biol. Chem., December 13, 1996; 271(50): 31791 - 31794.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society